The global rare disease genetic testing market is gaining momentum as awareness, technology, and patient registries continue to expand. With rapid advancements in next-generation sequencing (NGS) and strong government support, the market is poised for significant growth in the coming years. The rare disease genetic testing market was valued at USD 1.15 Billion in 2024 and is...